Cefpodoxime Proxetil Tablets Market

Cefpodoxime proxetil tablet is a third-generation, broad-spectrum, powerful cephalosporin antibacterial drug, effective against gram-negative and positive bacteria including anaerobic bacteria
Cefpodoxime Proxetil Tablets Market contains market size and forecasts of Cefpodoxime Proxetil Tablets in global, including the following market information:
Global Cefpodoxime Proxetil Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cefpodoxime Proxetil Tablets Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cefpodoxime Proxetil Tablets companies in 2021 (%)
The global Cefpodoxime Proxetil Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cefpodoxime Proxetil Tablets include Pfizer, Novartis, Sun Pharma, Cadila Healthcare, Lupin, Aurobindo Pharma, Torrent Pharma, Innova Captab and Wellona Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cefpodoxime Proxetil Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cefpodoxime Proxetil Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefpodoxime Proxetil Tablets Market Segment Percentages, by Type, 2021 (%)
100mg
200mg
Other
Global Cefpodoxime Proxetil Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefpodoxime Proxetil Tablets Market Segment Percentages, by Application, 2021 (%)
Respiratory Tract Infection
Skin and Soft Tissue Infections
Urinary Tract Infection
Other
Global Cefpodoxime Proxetil Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefpodoxime Proxetil Tablets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cefpodoxime Proxetil Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cefpodoxime Proxetil Tablets revenues share in global market, 2021 (%)
Key companies Cefpodoxime Proxetil Tablets sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cefpodoxime Proxetil Tablets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Sun Pharma
Cadila Healthcare
Lupin
Aurobindo Pharma
Torrent Pharma
Innova Captab
Wellona Pharma
SwisscheM Healthcare
West Coast Pharmaceuticals
Skymax Life Science
Zhejiang Jingxin Pharmaceutical
Hainan Hailing Chemipharma Corporation
Zhejiang Kangle Pharmaceutical
Dawnrays Pharma
Sichuan Hexin